Medical News

RSS

BIOTONE donates $5,000 to Council of Community Clinics for breast cancer research

BIOTONE announces a donation of $5,000 to the Council of Community Clinics to help fund diagnostics for breast cancer. The San Diego-based Council of Community Clinics provides centralized support services to 16 member community clinic and health center organizations operating nearly 100 sites in San Diego, Imperial, and Riverside Counties in California.

21 Oct 2010

Metabolon receives patent for biomarkers to determine PPAR-affecting drugs

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.

21 Oct 2010

Quark initiates dosing NAION patients in QPI-1007 Phase I study for ocular neuroprotection

Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced it has dosed the first patient with recent onset of non-arteritic anterior ischemic optic neuropathy (NAION) in its ongoing Phase I study of QPI-1007, the Company's proprietary synthetic siRNA drug candidate for ocular neuroprotection.

21 Oct 2010

More groups challenge Democrats on health issues as GOP lays out repeal clues

Procedural motions that Republicans filed during the healthcare reform debate offer the best insights into which provisions of the law the party wants to repeal first, a top staffer for a senior House Republican told The Hill.

21 Oct 2010

Researchers suggest 'watch and wait' strategy for girls with germ-cell ovarian tumors

Researchers from Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) have found that as many as 50 percent of young girls treated for germ-cell ovarian tumors might safely be spared chemotherapy using a "watch and wait" strategy to determine if the follow-up treatment is needed.

21 Oct 2010

Report finds shortage of Mass. physicians is getting worse

The Boston Herald: "The state's physician shortage is getting worse -- with many practices closed to new patients and a critical need for doctors in key specialties, according to a Massachusetts Medical Society report released today. ... The most acute need is for primary-care physicians who practice family or internal medicine. The study called the shortages in those two key areas 'critical.'

21 Oct 2010

NASA establishes Human Health and Performance Center

NASA has established a global forum for organizations interested in advancing human health and performance innovations in space and on Earth. NASA's Human Health and Performance Center (NHHPC) will give members an opportunity to collaborate, network and share information.

21 Oct 2010

Hormone therapy increases breast cancer mortality risk, study finds

Hormone treatment after menopause, already known to increase the risk of breast cancer, also makes it more likely that the cancer will be advanced and deadly, a study finds.

21 Oct 2010

Researchers identify common link among malignant tumor types in all grades of cancer

Researchers from Mount Sinai School of Medicine, in collaboration with investigators of the National Institute of Health and Medical Research (INSERM) of France led by Nicolae Ghinea, PhD, have found a common link among several malignant tumor types in all grades of cancer. This breakthrough may ultimately provide a new diagnostic or therapeutic target to detect cancer early or stop tumor growth.

21 Oct 2010

Study on health effects of alcohol consumption with HIV

Living with HIV is difficult under the best of circumstances, but for people carrying the virus, alcohol consumption can become particularly perilous in intricate ways that are only beginning to be understood. At the Brown Alcohol Research Center on HIV (ARCH) funded by a new $7.5-million, five-year grant from the National Institutes of Health, Brown University scientists will study the health effects of drinking with HIV and provide doctors and patients with the latest guidance their results suggest.

21 Oct 2010

Partnership between institutions in high- and low-resource areas can improve pediatric sarcoma treatment

Raising the survival rate of children with sarcoma in low-income countries will require steps to diagnose the disease sooner, train cancer pathologists, expand radiation therapy services, create multi-specialty teams to review each case, and other actions, according to an international study led by Dana-Farber/Children's Hospital Cancer Center researchers. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Friday, Oct. 22.

21 Oct 2010

Employers not dropping coverage as Mental Health Parity law is enacted

American Medical News: The Mental Health Parity and Addiction Equity Act hasn't made employers drop coverage as some feared it might. The full effects won't be felt until early 2011 as health plans begin their new enrollment years, but "[e]arly indications ... are that relatively few employers are dropping mental health coverage in response to the law's mandate, a concern of some of the bill's opponents."

21 Oct 2010

Idaho halts Medicaid cuts for dental care; Georgia and justice department reach accord on mental health services

Gov. C.L. 'Butch' Otter removed a political abscess Tuesday, restoring all previously contracted dental care providers to the state's Medicaid-funded Idaho Smiles program.

21 Oct 2010

Agensys and Seattle Genetics initiate ASG-5ME phase I clinical trial for castration-resistant prostate cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of castration-resistant prostate cancer. ASG-5ME is an antibody-drug conjugate (ADC) targeting the SLC44A4 antigen and is being co-developed by both companies for the treatment of solid tumors.

21 Oct 2010

Valensa enters agreement with Mercola for Flex Pro ES formulation

Valensa International and Mercola Health Resources, LLC announced today that they have entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES(TM) joint health formulation.

21 Oct 2010

Menopausal estrogen replacement therapy speeds growth of ovarian cancer

Estrogen therapy used by menopausal women causes a type of ovarian cancer to grow five times faster, according to a new study by researchers at the University of Colorado Cancer Center.

21 Oct 2010

Cost of health plans rise, but health law only one reason

Most Ohioans will face higher health insurance premiums starting in January with hikes ranging from 8 percent to 18 percent giving rise to fresh complaints about the White House-backed health care law.

21 Oct 2010

Burn injuries in children show vitamin E depletion in fat tissues

Severe burn injuries in children have been shown to rapidly deplete the levels of vitamin E in their body's adipose, or fat tissues, a new clinical study has found.

21 Oct 2010

HHS did not violate federal law for Medicare ads, GAO says

The Hill Healthwatch: "The Department of Health and Human Services did not violate federal prohibitions on publicity and propaganda with its health reform advertising and technical assistance contracts, the Government Accountability Office said Tuesday. Two HHS television ads, however, 'overstate one of (the law's) benefits,' GAO writes in a letter to Reps. Dave Camp (R-Mich.) and Darrell Issa (R-Calif.). The lawmakers requested the office's legal opinion about the ads and HHS's contracts with MIT economist Jonathan Gruber.

21 Oct 2010

Access submits additional patent applications for Cobalamin-mediated oral drug delivery technology

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.

21 Oct 2010

Medical News

BIOTONE donates $5,000 to Council of Community Clinics for breast cancer research

Metabolon receives patent for biomarkers to determine PPAR-affecting drugs

Quark initiates dosing NAION patients in QPI-1007 Phase I study for ocular neuroprotection

More groups challenge Democrats on health issues as GOP lays out repeal clues

Researchers suggest 'watch and wait' strategy for girls with germ-cell ovarian tumors

Report finds shortage of Mass. physicians is getting worse

NASA establishes Human Health and Performance Center

Hormone therapy increases breast cancer mortality risk, study finds

Researchers identify common link among malignant tumor types in all grades of cancer

Study on health effects of alcohol consumption with HIV

Partnership between institutions in high- and low-resource areas can improve pediatric sarcoma treatment

Employers not dropping coverage as Mental Health Parity law is enacted

Idaho halts Medicaid cuts for dental care; Georgia and justice department reach accord on mental health services

Agensys and Seattle Genetics initiate ASG-5ME phase I clinical trial for castration-resistant prostate cancer

Valensa enters agreement with Mercola for Flex Pro ES formulation

Menopausal estrogen replacement therapy speeds growth of ovarian cancer

Cost of health plans rise, but health law only one reason

Burn injuries in children show vitamin E depletion in fat tissues

HHS did not violate federal law for Medicare ads, GAO says

Access submits additional patent applications for Cobalamin-mediated oral drug delivery technology

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News